在宅ヘルスケア産業の世界市場：2024年～2031年

概要

世界の在宅ヘルスケア産業市場は、2023年に2,695億3,000万米ドルに達し、2031年には4,742億5,000万米ドルに達すると予測され、予測期間2024-2031年のCAGRは7.32%で成長する見込みです。

世界の在宅ヘルスケア産業市場は、高齢化と慢性疾患の蔓延による在宅ケアサービス需要の高まりにより急拡大しています。在宅ヘルスケアには、看護ケア、理学療法、遠隔医療、福祉機器などさまざまなサービスが含まれます。このケアモデルは患者に自宅で医療を受ける利便性を提供し、ひいては入院の必要性を低下させ、ヘルスケア費用を削減します。

糖尿病、心臓病、呼吸器疾患などの慢性疾患を持つ患者の管理に不可欠なツールとなった遠隔医療や遠隔患者モニタリングの普及が、この業界の成長をさらに後押ししています。米国メディケア・メディケイド・サービスセンター（CMS）や世界保健機関（WHO）などの規制枠組みは、在宅ヘルスケアサービスの品質と安全性の標準化に重要な役割を果たしています。

アジア太平洋地域は、高齢者人口の増加、テクノロジーの導入、病院の混雑を緩和するための政府の取り組みにより、在宅ヘルスケア市場として急成長している国のひとつです。日本、中国、インドなどの国々では、在宅での高齢者介護を推進する政府の政策に支えられ、在宅ヘルスケアサービスの需要が急増しています。世界で最も急速に高齢化が進んでいる国のひとつである日本では、在宅ヘルスケア技術への投資が顕著です。

ダイナミクス

技術の進歩と高齢化

技術革新と世界人口の高齢化は、在宅ヘルスケア市場の主要促進要因です。スマートモニター、遠隔医療プラットフォーム、ウェアラブルデバイスなどの先進ヘルスケア機器は、在宅ヘルスケアに不可欠なものとなりつつあります。これらの技術は慢性疾患の管理を助け、病院通いを減らし、患者ケアの全体的な効率を高めます。例えば、ウェアラブル心臓モニターはヘルスケアプロバイダーに即座に最新情報を提供し、必要に応じて迅速な介入を可能にします。

高齢者人口の増加も大きな推進力となっています。国連（UN）によると、世界の80歳以上の人口は2019年から2050年の間に1億4,300万人から4億2,600万人へと3倍に増加すると予想されています。高齢者は病院に長期入院して高額な医療費を負担する代わりに、自宅で介護を受けることを選ぶため、このような特定の人口層の増加は在宅ヘルスケアサービスの必要性を高めることにつながります。

ヘルスケア費用の上昇と政府の支援

医療費の増加により、患者や医療提供者は経済的な選択肢を求めるようになり、在宅ヘルスケアは病院での治療と比べて大幅なコスト削減を実現しています。US Centers for Medicare & Medicaid Services（CMS）によると、在宅ヘルスケアは慢性疾患の管理や手術後の回復に費用対効果の高い選択肢であり、病院での治療よりも格段に安いです。予算が限られる中、ヘルスケアシステムは在宅ヘルスケアサービスの利用を促進するため、償還政策や税制優遇措置という形で政府からの援助を増やしています。

さらに米国労働統計局は、2020年から2030年にかけて在宅ヘルスケア業界における雇用機会が29％増加すると予測しており、これは全職種の平均成長率を上回り、ヘルスケアサービスにおけるこの分野の重要性が増していることを浮き彫りにしています。さらに、在宅ヘルスケアに対する世界のヘルスケア支出は毎年顕著な成長率で増加すると予想されるため、こうした政府の取り組みは市場を前進させるために不可欠です。この増加は、高齢者人口が多く、病院制度が手薄な国々で特に顕著です。

労働力不足と規制上の課題

在宅ヘルスケア産業の成長を妨げる主な要因は、労働力不足と規制上のハードルです。看護師や補助者を含む有資格の在宅ヘルスケア従事者の不足は、特に地方でのサービス提供に負担をかけています。WHOは、2030年までにユニバーサル・ヘルス・カバレッジを加速させるためには、特に低・中所得国において1,800万人の医療従事者が不足すると予測しており、在宅ヘルスケアの問題を悪化させています。

さらに、規制上の課題が市場成長の抑制要因となっています。医療規制が厳しい国では、償還プロセス、在宅ヘルスケアプロバイダーの認定要件、デジタルヘルスモニタリングツールの使用をめぐるプライバシーに関する懸念などの障壁に直面する可能性があります。こうした規制のボトルネックは、在宅ヘルスケアにおける新しい技術やサービスの採用をしばしば遅らせます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 技術の進歩と高齢化
    • ヘルスケアコストの上昇と政府支援
  • 抑制要因
    • 労働力不足と規制上の課題
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• ロシア・ウクライナ戦争影響分析
• DMIの見解

第6章 サービス別

• サービス
  • 医師によるプライマリーケア
  • 看護ケア
  • 理学/作業/言語療法
  • 栄養サポート
  • 介護
  • その他
• 製品
  • 治療製品
  • 検査、スクリーニング、モニタリング製品
  • モビリティケア製品
  • その他

第7章 適応症別

• がん
• 神経疾患
• モビリティ障害
• 糖尿病
• 心血管疾患
• その他

第8章 持続可能性分析

• 環境分析
• 経済分析
• ガバナンス分析

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第11章 企業プロファイル

• Omron Healthcare, Inc
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• 3M
• Air Liquide
• B. Braun Melsungen AG
• Linde plc
• GE HealthCare
• Koninklijke Philips N.V.,
• Dickinson and Company
• A&D Company Limited
• Addus HomeCare Corporation.

第12章 付録

Overview

Global Home Healthcare Industry Market reached US$ 269.53 billion in 2023 and is expected to reach US$ 474.25 billion by 2031, growing with a CAGR of 7.32% during the forecast period 2024-2031.

The global home healthcare industry market is expanding rapidly due to the rising demand for in-home care services driven by an aging population and an increased prevalence of chronic diseases. Home healthcare includes a variety of services such as nursing care, physical therapy, telehealth and assistive devices. This care model provides patients with the convenience of receiving medical care at home, which in turn lowers the necessity for hospitalization and reduces healthcare expenses.

The industry's growth is further propelled by the widespread adoption of telemedicine and remote patient monitoring, which have become essential tools for managing patients with chronic conditions like diabetes, heart disease and respiratory disorders. Regulatory frameworks, such as those set by US Centers for Medicare & Medicaid Services (CMS) and the World Health Organization (WHO), have played a crucial role in standardizing quality and safety in-home healthcare services.

Asia-Pacific is becoming one of the fastest growing markets for home healthcare due to the increasing elderly population, adoption of technology and government efforts to decrease hospital congestion. Countries such as Japan, China and India are witnessing a surge in demand for home healthcare services, supported by government policies promoting elderly care at home. Japan, with one of the world's most rapidly aging populations, has seen significant investment in home healthcare technologies.

Dynamics

Technological Advancements and Aging Population

Technological innovations, coupled with the aging global population, are key drivers in the home healthcare market. Advanced healthcare devices such as smart monitors, telehealth platforms and wearable devices are becoming integral to in-home medical care. These technologies aid in the management of chronic conditions, lessen hospital trips and enhance overall efficiency in patient care. For instance, wearable heart monitors can offer healthcare providers instant updates, allowing for prompt interventions as necessary.

The increasing elderly population is another major driver. According to the United Nations (UN), the global number of people aged 80 years or older is expected to triple between 2019 and 2050, increasing from 143 million to 426 million. The increase in this specific demographic leads to a greater need for home healthcare services, as elderly people opt to be cared for in their own homes instead of staying in hospitals for long periods and incurring high healthcare expenses.

Rising Healthcare Costs and Government Support

The increasing expense of healthcare is driving patients and healthcare providers to seek economical options, with home healthcare providing substantial cost savings in comparison to hospital treatment. According to the Centers for Medicare & Medicaid Services (CMS), home healthcare is a cost-effective option for managing chronic diseases and recovering from surgeries, as it is notably cheaper than hospital care. With budget limitations, healthcare systems are gaining more government aid in the form of reimbursement policies and tax incentives to promote the use of home healthcare services.

Furthermore, US Bureau of Labor Statistics predicts a 29% increase in job opportunities within the home healthcare industry from 2020 to 2030, surpassing the average growth rate for all professions and highlighting the sector's increasing significance in healthcare services. Additionally, government efforts like these are essential for driving the market forward, as global healthcare expenditures on home healthcare are expected to increase with a notable growth rate each year. This increase is particularly noticeable in nations with elderly populations and overwhelmed hospital systems.

Workforce Shortages and Regulatory Challenges

Workforce shortages and regulatory hurdles are the key factors that hamper the growth of the home healthcare industry. A shortage of qualified home healthcare workers, including nurses and aides, is placing a strain on service delivery, especially in rural areas. WHO projects a shortfall of 18 million health workers to accelerate universal health coverage by 2030, particularly in low- and lower-middle-income countries, exacerbating the issue of home healthcare.

Additionally, regulatory challenges pose a restraint on market growth. Countries with stringent healthcare regulations may face barriers in terms of reimbursement processes, certification requirements for home healthcare providers and privacy concerns surrounding the use of digital health monitoring tools. These regulatory bottlenecks often slow down the adoption of new technologies and services in home healthcare.

Segment Analysis

The global home healthcare industry market is segmented based on offering, indication and region.

Demand for Assistive Devices and Remote Monitoring Tools

The demand for home healthcare market is driven by the adoption of assistive devices and remote monitoring tools. The devices help manage chronic diseases and enable elderly or disabled individuals to live more independently. According to the United Nations, the global population aged 60 years or over is expected to double by 2050, driving increased demand for devices like mobility aids, oxygen delivery systems and home dialysis equipment.

Telehealth and remote patient monitoring are also experiencing significant demand as they enable healthcare providers to monitor patient's conditions without the need for in-person visits. Furthermore, advancements in communication technologies and the increasing prevalence of chronic conditions such as diabetes and hypertension also drive the home health market growth. Moreover, these tools reduce the burden on healthcare systems by allowing for continuous monitoring and early intervention, which can help prevent hospital readmissions and improve overall patient outcomes.

Geographical Penetration

Demand for Home-Based Medical Services in North America

North America dominates the global home healthcare market, driven by a strong demand for home-based medical services, particularly for managing chronic diseases like cardiovascular disease (CVD) and cancer. According to the Centers for Disease Control and Prevention (CDC), heart disease accounted for 680,909 deaths in US in 2023, making it the third leading cause of death. With cancer (613,331 deaths) and unintentional injuries (222,518 deaths) also among the top causes, the need for at-home healthcare solutions for chronic disease management has intensified.

US healthcare system is increasingly adopting home healthcare solutions as a cost-effective alternative to hospital-based care. As healthcare costs continue to rise, patients are seeking home-based treatment options for post-surgery recovery and chronic disease management. US government's support, through reimbursement policies and tax incentives, further drives the adoption of home healthcare technologies and services.

Competitive Landscape

The major global players in the market include Omron Healthcare, Inc, 3M, Air Liquide, B. Braun Melsungen AG, Linde plc, GE HealthCare, Koninklijke Philips N.V., Dickinson and Company, A&D Company Limited and Addus HomeCare Corporation.

Sustainability Analysis

Sustainability is becoming an increasingly important factor in the global home healthcare industry, with a growing emphasis on reducing the environmental impact of medical waste and energy consumption. The adoption of energy-efficient medical equipment and telehealth tools is reducing the healthcare sector's carbon footprint, as digital healthcare technologies are decreasing the reliance on physical infrastructure.

According to the Global Sustainability Council for Healthcare (GSCH), the home healthcare market can contribute significantly to global sustainability goals by reducing the need for hospital infrastructure, thereby decreasing energy consumption and waste generation. Specifically, remote patient monitoring systems and telemedicine help decrease the need for patients to travel and be admitted to the hospital, supporting a more sustainable healthcare system. Furthermore, companies are increasingly focused on designing recyclable and biodegradable medical devices, aligning with global environmental regulations and consumer demand for eco-friendly solutions.

Russia-Ukraine War Impact

The ongoing Russia-Ukraine war has created both direct and indirect challenges for the global home healthcare industry. One of the main impacts has been the disruption of medical device and healthcare supply chains across Europe. Ukraine is an essential provider of electronic parts for medical equipment, including those for home medical care. The conflict has caused disruptions in the supply chain, resulting in shortages and higher prices for medical devices, which has in turn delayed the adoption of home healthcare technologies.

Moreover, with the geopolitical situation resulting in a significant humanitarian crisis, healthcare systems in neighboring countries have been overwhelmed by the influx of refugees. This situation has redirected healthcare resources, including home healthcare services, to crisis management. Furthermore, governments in impacted areas are increasing financial allocation to military expenses, possibly leading to a decrease in funding for healthcare, such as home healthcare initiatives.

By Offering

• Services
  • Physician primary care
  • Nursing care
  • Physical/occupational/speech therapy
  • Nutritional support
  • Unskilled Care
  • Others
• Products
  • Therapeutic Products
  • Testing, Screening and Monitoring Products
  • Mobility Care Products
  • Others

By Indication

• Cancer
• Neurological Disorders
• Mobility Disorders
• Diabetes
• Cardiovascular Disorders
• Others

Region

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Key Developments

• In June 2023, Amedisys, a leading provider of personalized home health and hospice care, announced its agreement to combine with Optum, a diversified health services company. Amedisys provides specialized care to patients in their homes through over 11.2 million home visits each year. This merger is intended to improve the provision of complete home healthcare services, leading to better patient results and increasing their presence in the expanding home healthcare industry.
• In February 2023, 3M launched a new medical adhesive designed for use with a variety of sensors, health monitors and long-term medical wearables. This strategic move helped 3M broaden its product offering in the home healthcare space, particularly in medical wearables, by catering to the growing demand for remote patient monitoring solutions.
• In November 2022, the Pennant Group, Inc. acquired a Wisconsin-based home health provider to deliver skilled home health and community health services in Kenosha, Wisconsin. This acquisition reflects Pennant's strategy to strengthen its footprint in the home healthcare market.

Why Purchase the Report?

• To visualize the global home healthcare industry market segmentation based on offering, indication and region.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel spreadsheet containing a comprehensive dataset of the home healthcare industry market, covering all levels of segmentation.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global home healthcare industry market report would provide approximately 46 tables, 35 figures and 201 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Offering
• 3.2. Snippet by Indication
• 3.3. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Technological Advancements and Aging Population
    • 4.1.1.2. Rising Healthcare Costs and Government Support
  • 4.1.2. Restraints
    • 4.1.2.1. Workforce Shortages and Regulatory Challenges
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Russia-Ukraine War Impact Analysis
• 5.6. DMI Opinion

6. By Offering

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
  • 6.1.2. Market Attractiveness Index, By Offering
• 6.2. Services*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.2.1. Physician primary care
    • 6.2.2.2. Nursing care
    • 6.2.2.3. Physical/occupational/speech therapy
    • 6.2.2.4. Nutritional support
    • 6.2.2.5. Unskilled Care
    • 6.2.2.6. Others
• 6.3. Products
  • 6.3.1. Introduction
  • 6.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.3.2.1. Therapeutic Products
    • 6.3.2.2. Testing, Screening and Monitoring Products
    • 6.3.2.3. Mobility Care Products
    • 6.3.2.4. Others

7. By Indication

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 7.1.2. Market Attractiveness Index, By Indication
• 7.2. Cancer*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Neurological Disorders
• 7.4. Mobility Disorders
• 7.5. Diabetes
• 7.6. Cardiovascular Disorders
• 7.7. Others

8. Sustainability Analysis

• 8.1. Environmental Analysis
• 8.2. Economic Analysis
• 8.3. Governance Analysis

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.5.1. US
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.5.1. Germany
    • 9.3.5.2. UK
    • 9.3.5.3. France
    • 9.3.5.4. Italy
    • 9.3.5.5. Spain
    • 9.3.5.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.5.1. Brazil
    • 9.4.5.2. Argentina
    • 9.4.5.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.5.1. China
    • 9.5.5.2. India
    • 9.5.5.3. Japan
    • 9.5.5.4. Australia
    • 9.5.5.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Omron Healthcare, Inc*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. 3M
• 11.3. Air Liquide
• 11.4. B. Braun Melsungen AG
• 11.5. Linde plc
• 11.6. GE HealthCare
• 11.7. Koninklijke Philips N.V.,
• 11.8. Dickinson and Company
• 11.9. A&D Company Limited
• 11.10. Addus HomeCare Corporation.

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us